Mobile Health Support Before Oocyte Pick-Up in Infertile Women (NCT07690969) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Mobile Health Support Before Oocyte Pick-Up in Infertile Women
Turkey (Türkiye)60 participantsStarted 2026-08-17
Plain-language summary
This study aims to evaluate the effect of the OPUCARE system, a structured mobile health application used before oocyte pick-up (OPU), on medication adherence and quality of life in infertile women. The study will also examine the possible effect of the intervention on state anxiety.
Participants will be randomly assigned to either the intervention group or the control group. The intervention group will receive routine clinical care plus the OPUCARE system. The control group will receive routine clinical care and standard written and verbal information provided by the clinic, without mobile health application support.
The intervention period will last approximately 2 weeks, from the start of medication treatment until oocyte pick-up. Medication adherence, quality of life, and state anxiety will be assessed before and after the intervention period.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female participants aged 18 years and older
* Diagnosed with primary infertility
* Scheduled to undergo oocyte pick-up (OPU) for the first time
* Newly starting medication treatment during the period before OPU
* Own a smartphone and are able to use basic mobile applications
* Willing to participate in the study and provide written informed consent
Exclusion Criteria:
* Diagnosis of secondary infertility
* Presence of a serious chronic disease that may significantly affect medication adherence and/or quality of life
* Presence of an active serious psychiatric disorder
* Cognitive or physical limitation that prevents use of the mobile application
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in medication adherence score
Timeframe: Baseline and the day before oocyte pick-up (approximately 2 weeks after baseline)
2
Change in fertility-related quality of life score
Timeframe: Baseline and the day before oocyte pick-up (approximately 2 weeks after baseline)